New approval allows teplizumab use in children as young as 1 year, significantly delaying stage 3 type 1 diabetes onset and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results